OCULAR HYPERTENSION
Clinical trials for OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glaucoma Drug-Delivering contact lens put to the test
Disease control TerminatedThis study tested a special contact lens that slowly releases the glaucoma drug latanoprost, aiming to replace daily eye drops. Only one person enrolled before the study was stopped early. The goal was to check if the lens is safe, comfortable, and works to lower eye pressure.
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Eye drop combo study for glaucoma halted early
Disease control TerminatedThis study tested two different combinations of eye drops to see which worked better for lowering eye pressure in people with open-angle glaucoma or high eye pressure. The study planned to include 28 adults whose condition was not controlled by standard medications. Participants …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE4 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Tiny drops, big hope: new device may ease glaucoma treatment
Symptom relief TerminatedThis study tested a device called Nanodropper that makes smaller eye drops for people with glaucoma or high eye pressure. The goal was to see if smaller drops work just as well as standard drops to lower eye pressure. The study planned to enroll 16 adults who already use a common…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC